Search results from the "OB_Rx" table for query
on "021687."
| Active Ingredient: | EZETIMIBE; SIMVASTATIN |
| Dosage Form;Route: | TABLET; ORAL |
| Proprietary Name: | VYTORIN |
| Applicant: | MSP SINGAPORE |
| Strength: | 10MG;10MG |
| Application Number: | 021687 |
| Product Number: | 001 |
| Approval Date: | Jul 23, 2004 |
| Reference Listed Drug | No |
| RX/OTC/DISCN: | RX |
| TE Code: | |
| Patent and Exclusivity Info for this product: | View |
|
|
|
| Active Ingredient: | EZETIMIBE; SIMVASTATIN |
| Dosage Form;Route: | TABLET; ORAL |
| Proprietary Name: | VYTORIN |
| Applicant: | MSP SINGAPORE |
| Strength: | 10MG;20MG |
| Application Number: | 021687 |
| Product Number: | 002 |
| Approval Date: | Jul 23, 2004 |
| Reference Listed Drug | No |
| RX/OTC/DISCN: | RX |
| TE Code: | |
| Patent and Exclusivity Info for this product: | View |
|
|
|
| Active Ingredient: | EZETIMIBE; SIMVASTATIN |
| Dosage Form;Route: | TABLET; ORAL |
| Proprietary Name: | VYTORIN |
| Applicant: | MSP SINGAPORE |
| Strength: | 10MG;40MG |
| Application Number: | 021687 |
| Product Number: | 003 |
| Approval Date: | Jul 23, 2004 |
| Reference Listed Drug | No |
| RX/OTC/DISCN: | RX |
| TE Code: | |
| Patent and Exclusivity Info for this product: | View |
|
|
|
| Active Ingredient: | EZETIMIBE; SIMVASTATIN |
| Dosage Form;Route: | TABLET; ORAL |
| Proprietary Name: | VYTORIN |
| Applicant: | MSP SINGAPORE |
| Strength: | 10MG;80MG |
| Application Number: | 021687 |
| Product Number: | 004 |
| Approval Date: | Jul 23, 2004 |
| Reference Listed Drug | Yes |
| RX/OTC/DISCN: | RX |
| TE Code: | |
| Patent and Exclusivity Info for this product: | View |
|
|
|
Return to Electronic Orange Book Home Page
| FDA/Center for Drug Evaluation and Research |
| Office of Generic Drugs |
| Division of Labeling and Program Support |
| Update Frequency: |
| Orange Book Data - Monthly |
| Generic Drug Product Information & Patent Information - Daily |
| Orange Book Data Updated Through December, 2008 |
| Patent and Generic Drug Product Data Last Updated: February 06, 2009 |